Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil
- 1 October 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (15) , 2053-2055
- https://doi.org/10.1097/00002030-200110190-00023
Abstract
Co-infection with HTLV-1 reaches 20% among patients infected by HIV-1 in Bahia, Brazil. To evaluate its impact on survival, we conducted a retrospective, case-control study involving 198 patients (63 cases). Co-infection was associated with parenteral exposure (P = 0.0001) and female sex (P = 0.02). Co-infected patients had a shorter mean survival (1849 days) than controls (2430 days, P = 0.001), regardless of sex or baseline CD4 cell count. In Bahia, Brazil, co-infection with HIV-1 and HTLV-1 is associated with a shorter survival time.Keywords
This publication has 5 references indexed in Scilit:
- In Vitro Induction of HIV-1 Replication in Resting CD4+ T Cells Derived from Individuals with Undetectable Plasma Viremia upon Stimulation with Human T-Cell Leukemia Virus Type IVirology, 2000
- Differential Patterns of Interaction between HIV Type 1 and HTLV Type I in Monocyte-Derived Macrophages Cultured in Vitro : Implications for in Vivo Coinfection with HIV Type 1 and HTLV Type IAIDS Research and Human Retroviruses, 1999
- Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)–infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I–uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1The Journal of Experimental Medicine, 1998
- HTLV-I and HTLV-II Virus Expression Increase With HIV-1 CoinfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- HIV Viral Load and CD4+ Lymphocyte Counts in Subjects Coinfected With HTLV-I and HIV-1JAIDS Journal of Acquired Immune Deficiency Syndromes, 1997